Nikko Asset Management Americas’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-27,207
| Closed | -$12.4M | – | 225 |
|
|
2021
Q1 | $12.4M | Buy |
27,207
+3,282
| +14% | +$1.5M | 0.06% | 128 |
|
|
2020
Q4 | $11.1M | Sell |
23,925
-15,300
| -39% | -$7.13M | 0.06% | 125 |
|
|
2020
Q3 | $17.5M | Sell |
39,225
-3,344
| -8% | -$1.49M | 0.15% | 88 |
|
|
2020
Q2 | $15M | Sell |
42,569
-50,145
| -54% | -$17.7M | 0.2% | 71 |
|
|
2020
Q1 | $26.3M | Buy |
92,714
+19,390
| +26% | +$5.5M | 0.49% | 56 |
|
|
2019
Q4 | $23.8M | Sell |
73,324
-1,657
| -2% | -$538K | 0.38% | 65 |
|
|
2019
Q3 | $21.8M | Buy |
74,981
+9,338
| +14% | +$2.72M | 0.39% | 58 |
|
|
2019
Q2 | $19.3M | Buy |
65,643
+33,054
| +101% | +$9.71M | 0.38% | 61 |
|
|
2019
Q1 | $8.92M | Buy |
+32,589
| New | +$8.92M | 0.24% | 71 |
|
|
2018
Q1 | – | Sell |
-700
| Closed | -$132K | – | 247 |
|
|
2017
Q4 | $132K | Hold |
700
| – | – | ﹤0.01% | 203 |
|
|
2017
Q3 | $132K | Sell |
700
-1,400
| -67% | -$264K | 0.01% | 233 |
|
|
2017
Q2 | $366K | Hold |
2,100
| – | – | 0.02% | 202 |
|
|
2017
Q1 | $323K | Hold |
2,100
| – | – | 0.02% | 209 |
|
|
2016
Q4 | $296K | Sell |
2,100
-100
| -5% | -$14.1K | 0.02% | 213 |
|
|
2016
Q3 | $350K | Hold |
2,200
| – | – | 0.03% | 188 |
|
|
2016
Q2 | $319K | Hold |
2,200
| – | – | 0.03% | 190 |
|
|
2016
Q1 | $310K | Buy |
2,200
+100
| +5% | +$14.1K | 0.04% | 183 |
|
|
2015
Q4 | $300K | Sell |
2,100
-4,400
| -68% | -$629K | 0.03% | 165 |
|
|
2015
Q3 | $779K | Hold |
6,500
| – | – | 0.08% | 107 |
|
|
2015
Q2 | $841K | Hold |
6,500
| – | – | 0.06% | 112 |
|
|
2015
Q1 | $881K | Sell |
6,500
-11,300
| -63% | -$1.53M | 0.07% | 111 |
|
|
2014
Q4 | $2.25M | Buy |
17,800
+6,100
| +52% | +$772K | 0.16% | 81 |
|
|
2014
Q3 | $1.43M | Buy |
11,700
+9,500
| +432% | +$1.16M | 0.09% | 96 |
|
|
2014
Q2 | $260K | Hold |
2,200
| – | – | 0.01% | 176 |
|
|
2014
Q1 | $261K | Buy |
+2,200
| New | +$261K | 0.01% | 171 |
|